Hesitator | Acceptor | p value | |
---|---|---|---|
n = 31 | n = 674 | ||
Age, median (IQR) | 28.0 (27.0–29.0) | 30.0 (29.0–33.0) | < 0.01a |
Female, n (%)† | 18 (5.0%) | 341 (95.0%) | 0.47b |
Religion, n (%)† | 0.40b | ||
Buddhism | 28 (4.2%) | 634 (95.8%) | |
Christianity | 2 (9.5%) | 19 (90.5%) | |
Islam | 0 (0.0%) | 3 (100.0%) | |
Others | 1 (5.3%) | 18 (94.7%) | |
Presence of comorbidity, n (%)† | 4 (3.1%) | 125 (96.9%) | 0.63b |
Physician role, n (%)† | < 0.01b | ||
Resident | 28 (6.9%) | 378 (93.1%) | |
Fellow | 2 (1.6%) | 126 (98.4%) | |
Staff | 1 (0.6%) | 170 (99.4%) | |
Department, n (%)† | 0.04b | ||
General/Others | 10 (5.5%) | 171 (94.5%) | |
Medical | 16 (6.0%) | 249 (94.0%) | |
Surgical | 5 (1.9%) | 254 (98.1%) | |
Direct care of COVID-19 patients, n (%)† | < 0.01b | ||
Yes | 23 (6.9%) | 310 (93.1%) | |
No | 8 (2.2%) | 364 (97.8%) | |
High aerosolization work settings, n (%)† | 0.58b | ||
Yes | 16 (5.0%) | 306 (95.0%) | |
No | 15 (3.9%) | 368 (96.1%) | |
Previous influenza vaccination, n (%)† | 0.43b | ||
Never | 1 (5.0%) | 19 (95.0%) | |
Sometimes | 6 (2.9%) | 200 (97.1%) | |
Yearly | 24 (5.0%) | 455 (95.0%) | |
Preferred vaccine type, n (%)† | < 0.01b | ||
Inactivated | 1 (0.6%) | 161 (99.4%) | |
Viral vector | 7 (5.7%) | 115 (94.3%) | |
mRNA | 18 (7.2%) | 233 (92.8%) | |
Any | 5 (2.9%) | 165 (97.1%) | |
Information sources, n (%)† | |||
Articles/Scientific journal | 16 (3.5%) | 442 (96.5%) | 0.12b |
TV/Newspaper | 7 (2.8%) | 242 (97.2%) | 0.18b |
Social media | 26 (5.5%) | 447 (94.5%) | 0.05b |
Hospital media | 5 (1.7%) | 290 (98.3%) | < 0.01b |
Academic conference | 6 (3.1%) | 190 (96.9%) | 0.41b |
Friend/Family | 5 (2.8%) | 175 (97.2%) | 0.29b |
Others | 0 (0.0%) | 1 (100.0%) | 0.9b |
Willingness to recommend vaccine to family, n (%)† | < 0.01c | ||
Yes | 8 (1.4%) | 546 (98.6%) | |
No | 10 (50.0%) | 10 (50.0%) | |
Not sure | 13 (9.9%) | 118 (90.1%) | |
Willingness to recommend vaccine to patients, n (%)† | < 0.01c | ||
Yes | 11 (1.9%) | 562 (98.1%) | |
No | 3 (21.4%) | 11 (78.6%) | |
Not sure | 17 (14.4%) | 101 (85.6%) |